MiRNA and vascular cell movement

Advanced Drug Delivery Reviews

Volumn 63, Issue 8, 2011, Pages 616-622

  Yue, Junming ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Cell movement; MiRNA; Therapy; Vascular

Indexed keywords

BIOLOGICAL FUNCTIONS; CARDIO-VASCULAR DISEASE; CELL MOVEMENT; DIFFERENT MECHANISMS; EXPERIMENTAL EVIDENCE; HUMAN DISEASE; IN-VITRO; MIRNA; POST-TRANSCRIPTIONAL; SIGNALING PATHWAYS; SMALL RNA; THERAPY; VASCULAR; VASCULAR CELLS; VASCULAR DISEASE; VIRAL VECTORS;

CELL DEATH; DISEASE CONTROL; DRUG THERAPY; GENE EXPRESSION; GENE THERAPY; GENETIC ENGINEERING;

DISEASES;

ADENOVIRUS VECTOR; LENTIVIRUS VECTOR; MICRORNA; MICRORNA 122; MICRORNA 126; MICRORNA 132; MICRORNA 132 ANTIBODY; MICRORNA 143; MICRORNA 145; MICRORNA 15B; MICRORNA 16 1; MICRORNA 16 2; MICRORNA 16 ANTIBODY; MICRORNA 17; MICRORNA 18A; MICRORNA 19A; MICRORNA 19B 1; MICRORNA 20A; MICRORNA 21; MICRORNA 221; MICRORNA 222; MICRORNA 26A; MICRORNA 92A 1; MICRORNA ANTIBODY; NANOPARTICLE; PARVOVIRUS VECTOR; RNA; RNA ANTIBODY; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; DRUG DESIGN; DRUG FORMULATION; DRUG TARGETING; ENDOTHELIUM CELL; FEEDBACK SYSTEM; GENE CONTROL; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR INTERACTION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; REVIEW; RNA ANALYSIS; RNA EDITING; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CARDIOVASCULAR DISEASES; CELL MOVEMENT; DRUG DELIVERY SYSTEMS; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC VECTORS; HUMANS; MICRORNAS; NEOPLASMS;

EID: 79959954933     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2011.01.001     Document Type: Review

References (90)

1. Suzuki H.I., Miyazono K. Emerging complexity of microRNA generation cascades. J. Biochem. 2011, 149:15-25.
2. Lee Y., Ahn C., Han J., Choi H., Kim J., et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425:415-419.
3. Newman M.A., Hammond S.M. Emerging paradigms of regulated microRNA processing. Genes Dev. 2010, 24:1086-1092.
4. Dickstein J., Senyuk V., Premanand K., Laricchia-Robbio L., Xu P., et al. Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome. Proc. Natl Acad. Sci. USA 2010, 107:9783-9788.
5. Cai Y., Yu X., Hu S., Yu J. A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinform. 2009, 7:147-154.
6. Balaguer F., Link A., Lozano J.J., Cuatrecasas M., Nagasaka T., et al. Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res. 2010, 70:6609-6618.
7. Furuta M., Kozaki K.I., Tanaka S., Arii S., Imoto I., et al. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010, 31:766-776.
8. Vrba L., Jensen T.J., Garbe J.C., Heimark R.L., Cress A.E., et al. Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells. PLoS ONE 2010, 5:e8697.
9. Hashimoto Y., Akiyama Y., Otsubo T., Shimada S., Yuasa Y. Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis. Carcinogenesis 2010, 31:777-784.
10. Shen R., Pan S., Qi S., Lin X., Cheng S. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer. Biochem. Biophys. Res. Commun. 2010, 394:1047-1052.
11. Yang W., Chendrimada T.P., Wang Q., Higuchi M., Seeburg P.H., et al. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat. Struct. Mol. Biol. 2006, 13:13-21.
12. Kawahara Y., Zinshteyn B., Chendrimada T.P., Shiekhattar R., Nishikura K. RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. EMBO Rep. 2007, 8:763-769.
13. Han J., Pedersen J.S., Kwon S.C., Belair C.D., Kim Y.K., et al. Posttranscriptional crossregulation between Drosha and DGCR8. Cell 2009, 136:75-84.
14. Zhang X., Zeng Y. The terminal loop region controls microRNA processing by Drosha and Dicer. Nucleic Acids Res. 2010, 38:7689-7697.
15. Trabucchi M., Briata P., Garcia-Mayoral M., Haase A.D., Filipowicz W., et al. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 2009, 459:1010-1014.
16. Suzuki H.I., Yamagata K., Sugimoto K., Iwamoto T., Kato S., et al. Modulation of microRNA processing by p53. Nature 2009, 460:529-533.
17. Davis B.N., Hilyard A.C., Lagna G., Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008, 454:56-61.
18. Iliopoulos D., Hirsch H.A., Struhl K. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 2009, 139:693-706.
19. Zhao C., Sun G., Li S., Shi Y. A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination. Nat. Struct. Mol. Biol. 2009, 16:365-371.
20. Yu Z., Wang C., Wang M., Li Z., Casimiro M.C., et al. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J. Cell Biol. 2008, 182:509-517.
21. Tokumaru S., Suzuki M., Yamada H., Nagino M., Takahashi T. let-7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis 2008, 29:2073-2077.
22. Petrocca F., Visone R., Onelli M.R., Shah M.H., Nicoloso M.S., et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008, 13:272-286.
23. Cheloufi S., Dos Santos C.O., Chong M.M., Hannon G.J. A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature 2010, 465:584-589.
24. Yang J.S., Maurin T., Robine N., Rasmussen K.D., Jeffrey K.L., et al. Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis. Proc. Natl Acad. Sci. USA 2010, 107:15163-15168.
25. Bernstein E., Kim S.Y., Carmell M.A., Murchison E.P., Alcorn H., et al. Dicer is essential for mouse development. Nat. Genet. 2003, 35:215-217.
26. Morita S., Horii T., Kimura M., Goto Y., Ochiya T., et al. One Argonaute family member, Eif2c2 (Ago2), is essential for development and appears not to be involved in DNA methylation. Genomics 2007, 89:687-696.
27. Albinsson S., Suarez Y., Skoura A., Offermanns S., Miano J.M., et al. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1118-1126.
28. Suarez Y., Fernandez-Hernando C., Yu J., Gerber S.A., Harrison K.D., et al. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc. Natl Acad. Sci. USA 2008, 105:14082-14087.
29. Kuehbacher A., Urbich C., Zeiher A.M., Dimmeler S. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ. Res. 2007, 101:59-68.
30. Asada S., Takahashi T., Isodono K., Adachi A., Imoto H., et al. Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H2512-H2521.
31. Mendell J.T. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008, 133:217-222.
32. Ventura A., Young A.G., Winslow M.M., Lintault L., Meissner A., et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008, 132:875-886.
33. Bonauer A., Carmona G., Iwasaki M., Mione M., Koyanagi M., et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009, 324:1710-1713.
34. Doebele C., Bonauer A., Fischer A., Scholz A., Reiss Y., et al. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood 2010, 115:4944-4950.
35. Dews M., Homayouni A., Yu D., Murphy D., Sevignani C., et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat. Genet. 2006, 38:1060-1065.
36. Elia L., Quintavalle M., Zhang J., Contu R., Cossu L., et al. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ. 2009, 16:1590-1598.
37. Cordes K.R., Sheehy N.T., White M.P., Berry E.C., Morton S.U., et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
38. Boettger T., Beetz N., Kostin S., Schneider J., Kruger M., et al. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J. Clin. Invest. 2009, 119:2634-2647.
39. Xin M., Small E.M., Sutherland L.B., Qi X., McAnally J., et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 2009, 23:2166-2178.
40. Larsson E., Fredlund Fuchs P., Heldin J., Barkefors I., Bondjers C., et al. Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1. Genome Med. 2009, 1:108.
41. Wang X., Hu G., Zhou J. Repression of versican expression by microRNA-143. J. Biol. Chem. 2010, 285:23241-23250.
42. Clape C., Fritz V., Henriquet C., Apparailly F., Fernandez P.L., et al. miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. PLoS ONE 2009, 4:e7542.
43. Sachdeva M., Mo Y.Y. miR-145-mediated suppression of cell growth, invasion and metastasis. Am. J. Transl. Res. 2010, 2:170-180.
44. Sachdeva M., Mo Y.Y. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res. 2010, 70:378-387.
45. Chiyomaru T., Enokida H., Tatarano S., Kawahara K., Uchida Y., et al. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br. J. Cancer 2010, 102:883-891.
46. Poliseno L., Tuccoli A., Mariani L., Evangelista M., Citti L., et al. MicroRNAs modulate the angiogenic properties of HUVECs. Blood 2006, 108:3068-3071.
47. Li Y., Song Y.H., Li F., Yang T., Lu Y.W., et al. microRNA-221 regulates high glucose-induced endothelial dysfunction. Biochem. Biophys. Res. Commun. 2009, 381:81-83.
48. Dentelli P., Rosso A., Orso F., Olgasi C., Taverna D., et al. microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1562-1568.
49. Davis B.N., Hilyard A.C., Nguyen P.H., Lagna G., Hata A. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J. Biol. Chem. 2009, 284:3728-3738.
50. Galardi S., Mercatelli N., Giorda E., Massalini S., Frajese G.V., et al. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J. Biol. Chem. 2007, 282:23716-23724.
51. le Sage C., Nagel R., Egan D.A., Schrier M., Mesman E., et al. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J. 2007, 26:3699-3708.
52. Mercatelli N., Coppola V., Bonci D., Miele F., Costantini A., et al. The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. PLoS ONE 2008, 3:e4029.
53. Garofalo M., Di Leva G., Romano G., Nuovo G., Suh S.S., et al. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 2009, 16:498-509.
54. Zhang C., Kang C., You Y., Pu P., Yang W., et al. Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo. Int. J. Oncol. 2009, 34:1653-1660.
55. Di Leva G., Gasparini P., Piovan C., Ngankeu A., Garofalo M., et al. microRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. J. Natl Cancer Inst. 2010, 102:706-721.
56. Frenquelli M., Muzio M., Scielzo C., Fazi C., Scarfo L., et al. microRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27. Blood 2010, 115:3949-3959.
57. Yue J., Tigyi G. Conservation of miR-15a/16-1 and miR-15b/16-2 clusters. Mamm. Genome 2010, 21:88-94.
58. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl Acad. Sci. USA 2005, 102:13944-13949.
59. Wang S., Aurora A.B., Johnson B.A., Qi X., McAnally J., et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 2008, 15:261-271.
60. Xia L., Zhang D., Du R., Pan Y., Zhao L., et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int. J. Cancer 2008, 123:372-379.
61. Xia H., Qi Y., Ng S.S., Chen X., Chen S., et al. MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells. Biochem. Biophys. Res. Commun. 2009, 380:205-210.
62. Satzger I., Mattern A., Kuettler U., Weinspach D., Voelker B., et al. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. Int. J. Cancer 2010, 126:2553-2562.
63. Karaa Z.S., Iacovoni J.S., Bastide A., Lacazette E., Touriol C., et al. The VEGF IRESes are differentially susceptible to translation inhibition by miR-16. RNA 2009, 15:249-254.
64. Hua Z., Lv Q., Ye W., Wong C.K., Cai G., et al. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS ONE 2006, 1:e116.
65. Senturia R., Faller M., Yin S., Loo J.A., Cascio D., et al. Structure of the dimerization domain of DiGeorge critical region 8. Protein Sci. 2010, 19:1354-1365.
66. Fish J.E., Santoro M.M., Morton S.U., Yu S., Yeh R.F., et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 2008, 15:272-284.
67. Nicoli S., Standley C., Walker P., Hurlstone A., Fogarty K.E., et al. microRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature 2010, 464:1196-1200.
68. van Solingen C., Seghers L., Bijkerk R., Duijs J.M., Roeten M.K., et al. Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. J. Cell. Mol. Med. 2009, 13:1577-1585.
69. Liu B., Peng X.C., Zheng X.L., Wang J., Qin Y.W. MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer 2009, 66:169-175.
70. Musiyenko A., Bitko V., Barik S. Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells. J. Mol. Med. 2008, 86:313-322.
71. Sarkar J., Gou D., Turaka P., Viktorova E., Ramchandran R., et al. MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010, 299:L861-L871.
72. Li T., Cao H., Zhuang J., Wan J., Guan M., et al. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clin. Chim. Acta 2011, 412:66-70.
73. Leeper N.J., Raiesdana A., Kojima Y., Chun H.J., Azuma J., et al. microRNA-26a is a novel regulator of vascular smooth muscle cell function. J. Cell. Physiol. 2010.
74. Huse J.T., Brennan C., Hambardzumyan D., Wee B., Pena J., et al. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev. 2009, 23:1327-1337.
75. Xu H., Yao Y., Smith L.P., Nair V. microRNA-26a-mediated regulation of interleukin-2 expression in transformed avian lymphocyte lines. Cancer Cell Int. 2010, 10:15.
76. Theodore S.C., Rhim J.S., Turner T., Yates C. MiRNA 26a expression in a novel panel of African American prostate cancer cell lines. Ethn. Dis. 2010, 20:S96-S100.
77. Xi Y., Formentini A., Chien M., Weir D.B., Russo J.J., et al. Prognostic values of microRNAs in colorectal cancer. Biomark Insights 2006, 2:113-121.
78. Anand S., Majeti B.K., Acevedo L.M., Murphy E.A., Mukthavaram R., et al. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat. Med. 2010, 16:909-914.
79. Krutzfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
80. Li J., Bai H., Zhu Y., Wang X.Y., Wang F., et al. Antagomir dependent microRNA-205 reduction enhances adhesion ability of human corneal epithelial keratinocytes. Chin. Med. Sci. J. 2010, 25:65-70.
81. Ma L., Reinhardt F., Pan E., Soutschek J., Bhat B., et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat. Biotechnol. 2010, 28:341-347.
82. Murphy E.A., Majeti B.K., Barnes L.A., Makale M., Weis S.M., et al. Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis. Proc. Natl Acad. Sci. USA 2008, 105:9343-9348.
83. Wahid F., Shehzad A., Khan T., Kim Y.Y. microRNAs: synthesis, mechanism, function, and recent clinical trials. Biochim. Biophys. Acta 2010, 1803:1231-1243.
84. Scherr M., Venturini L., Battmer K., Schaller-Schoenitz M., Schaefer D., et al. Lentivirus-mediated antagomir expression for specific inhibition of miRNA function. Nucleic Acids Res. 2007, 35:e149.
85. Ebert M.S., Sharp P.A. MicroRNA Sponges: Progress and Possibilities. RNA 2010, 20:R858-R861.
86. Bonci D., Coppola V., Musumeci M., Addario A., Giuffrida R., et al. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat. Med. 2008, 14:1271-1277.
87. Yang C.H., Yue J., Fan M., Pfeffer L.M. IFN induces miR-21 through a signal transducer and activator of transcription 3-dependent pathway as a suppressive negative feedback on IFN-induced apoptosis. Cancer Res. 2010, 70:8108-8116.
88. Kato Y., Sawata S.Y., Inoue A. A lentiviral vector encoding two fluorescent proteins enables imaging of adenoviral infection via adenovirus-encoded miRNAs in single living cells. J. Biochem. 2010, 147:63-71.
89. Yin K.J., Deng Z., Hamblin M., Xiang Y., Huang H., et al. Peroxisome proliferator-activated receptor delta regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury. J. Neurosci. 2010, 30:6398-6408.
90. Suzuki T., Sakurai F., Nakamura S., Kouyama E., Kawabata K., et al. miR-122a-regulated expression of a suicide gene prevents hepatotoxicity without altering antitumor effects in suicide gene therapy. Mol. Ther. 2008, 16:1719-1726.